(Q36016276)

English

Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Regine Sitruk-Ware

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Vivian Brache

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Robin Maguire

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Horacio Croxatto

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Narender Kumar

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sushma Kumar

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Juan Carlos Montero

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Ana Maria Salvatierra

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

David Phillips

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Anibal Faundes

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

18 April 2007

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

75

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

454-460

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Phase I safety study of 0.5% PRO 2000 vaginal Gel among HIV un-infected women in Pune, India

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Why consider vaginal drug administration?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Clinical development of microbicides for the prevention of HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Vaginal formulations of carrageenan protect mice from herpes simplex virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

The hormonal and peripheral effects of -norgestrel in postcoital contraception

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

2 October 2017

Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

11 July 2018

Pharmacokinetic and pharmacodynamic effects of vaginal rings releasing levonorgestrel at a rate of 27 micrograms/24 hours: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

11 July 2018

Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

11 July 2018

A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

11 July 2018

Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

11 July 2018

Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

11 July 2018

Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

11 July 2018

Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal vs. oral administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

Pharmacokinetics of levonorgestrel 0.75 mg tablets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

The pharmacokinetics of 750 microg levonorgestrel following administration of one single dose or two doses at 12- or 24-h interval

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

Vaginal spermicides and gonorrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1995403

23 September 2018

Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing of onset of contraceptive effectiveness in Norplant implant users. II. Effect on the ovarian function in the first cycle of use

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial clinical studies of intravaginal rings containing norethindrone and norgestrel

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills

1 reference

https://pubmed.ncbi.nlm.nih.gov/17519152

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.CONTRACEPTION.2007.02.003

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36016276&oldid=2143378093"